Top Markets
Coin of the day
Hoth Therapeutics, Inc. Hoth Therapeutics, Inc.

Hoth Therapeutics, Inc.

HOTH
Rangering i aksjer #32249
Hoth Therapeutics, Inc. engages in the development of new generation therapies... Hoth Therapeutics, Inc. engages in the development of new generation therapies for dermatological disorders. Its product pipeline focuses on potential treatments for indications including atopic dermatitis (also known as eczema), chronic wounds, psoriasis, asthma, and acne. It offers the BioLexa Platform, a drug compound platform for the treatment of eczema. The company was founded by Robbie Knie, Matthew D. Eitner, and James Ahern on May 16, 2017 and is headquartered in New York, NY.
Aksjekurs
$0.8013
Sist synkronisert: 2026-08-05
Markedsverdi
$10.62M
Endring (1 dag)
0.97%
Endring (1 år)
-37.88%
Land
US
Handel Hoth Therapeutics, Inc. (HOTH)

Kategori

Utbytteavkastning for Hoth Therapeutics, Inc. (HOTH)
Hoth Therapeutics, Inc. (aksjesymbol: HOTH) sin utbytteavkastning (TTM) per 2026 er: 0
Gjennomsnittlig utbytteavkastning de siste 5 årene: 0.00%
Utbytteavkastning for Hoth Therapeutics, Inc. (HOTH) fra 2026 til 2026
Utbytteavkastning ved slutten av hvert år (TTM)
År Utbytteavkastning Endre
Ikke nok data for de angitte datoene.
Utbytteavkastning (TTM) for lignende selskaper eller konkurrenter